Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective study of anidulafungin prescription for severe intra-abdominal yeast infections in ICU
2010-018695-25Phase 4Active
- Sponsor
- ADRFARCP
- Start
- Apr 2010
- Modality
- Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of anidulafungin in Intra-abdominal infection (IAI), sponsored by ADRFARCP. Primary endpoint: Clinical effectiveness outcome. Started Apr 2010; status: active.
02
Drugs
anidulafungin
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on 2010-018695-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018695-25.